Table 2 Chest CT criteria in COVID-19 patients
From: Prognostic impact of CT severity score in childhood cancer with SARS-CoV-2
| Findings | Total patient number | Mild (N = 45) | Moderate/severe (N = 19) | P value |
|---|---|---|---|---|
| Pulmonary findings | ||||
| Ground-glass opacity | 45 (70.3%) | 29 (64.4%) | 16 (84.2%) | 0.1142 |
| Consolidation | 40 (62.5%) | 24 (53.5%) | 16 (84.2%) | 0.0202* |
| GGO+consolidation | 29 (45.3%) | 15 (33.3%) | 14 (73.6%) | 0.0072* |
| Pulmonary nodules | 23 (35.9%) | 15 (33.3%) | 8 (42.1%) | 0.7012 |
| Fibrous bands | 16 (25%) | 8 (17.7%) | 8 (42.1%) | 0.0822 |
| Extrapulmonary findings | ||||
| Lymph nodes | 9 (14.05%) | 4 (8.8%) | 5 (26.3%) | 0.1111 |
| Pleural effusion | 9 (14.07%) | 3 (6.6%) | 6 (31.5%) | 0.0151* |
| Pericardial effusion | 5 (7.8%) | 1 (2.2%) | 4 (21.05%) | 0.0241* |